Profit & Loss

  • Company Name :
Bafna Pharmaceuticals Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532989
  • NSE Symbol:
  • BAFNAPH
  • P/E(TTM):
  • 249.03
  • ISIN Demat:
  • INE878I01022
  • Div & Yield%:
  • -
  • EPS(TTM):
  • 0.32
  • Book Value(₹):
  • 35.00
  • Market Cap(₹Cr.):
  • 188.52
  • Face Value(₹):
  • 10.00
Particulars Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
INCOME :          
Sales Turnover 152.47 115.35 85.14 71.22 42.47
Excise Duty - - - - -
Net Sales 152.47 115.35 85.14 71.22 42.47
Other Income 3.52 3.27 1.70 0.75 0.26
Stock Adjustments 4.85 2.91 1.77 -2.95 3.24
Total Income 160.84 121.53 88.61 69.02 45.97
EXPENDITURE :          
Raw Materials 91.58 65.98 41.70 33.58 23.22
Power and Fuel Cost 6.73 5.31 3.93 2.95 2.69
Other Manufacturing Expenses 13.83 8.68 7.72 6.72 5.02
Selling and Administration Expenses 13.98 5.39 6.92 2.67 3.18
Miscellaneous Expenses 1.06 1.33 2.19 0.07 23.45
Employee Benefit Expenses 19.03 15.87 14.65 11.98 10.25
Less: Preoperative Expenditure - - - - -
Total Expenses - - - - -
Operating Profit 14.63 18.99 11.50 11.04 -21.84
Interest 2.29 2.04 0.79 0.74 0.10
Gross Profit 12.34 16.95 10.71 10.30 -21.94
Depreciation 5.00 5.33 5.49 4.48 3.27
Profit Before Tax 7.34 11.62 5.22 5.82 -25.21
Current Tax - 0.28 - - -
Fringe Benefit tax - - - - -
Deferred Tax - - - - -
Reported Net Profit 7.35 11.34 5.22 5.83 -25.20
Extraordinary Items 0.07 0.20 -2.16 - -23.33
Adjusted Net Profit 7.28 11.14 7.38 5.83 -1.87
Adjustment below Net Profit 0.04 0.15 -0.02 - -
Profit/Loss Balance carried down -54.48 -65.97 -71.17 -76.99 -51.79
Statutory Appropriations - - - - -
Appropriations - - - - -
P & L Balance carried down -47.10 -54.48 -65.97 -71.17 -76.99
Dividend - - - - -
Preference Dividend - - - - -
Equity Dividend (%) - - - - -
Dividend Per Share(Rs) - - - - -
Earnings Per Share-Unit Curr 3.11 4.79 2.21 2.46 -106.54
Earnings Per Share(Adj)-Unit Curr 3.11 4.79 2.21 2.46 -106.54
Book Value 34.17 31.05 26.19 24.00 -18.64
Book Value(Adj)-Unit Curr 34.17 31.05 26.19 24.00 -18.64